These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 34352209)

  • 1. ApoE and immunity in Alzheimer's disease and related tauopathies: Low-density lipoprotein receptor to the rescue.
    Mendiola AS; Tognatta R; Yan Z; Akassoglou K
    Neuron; 2021 Aug; 109(15):2363-2365. PubMed ID: 34352209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms.
    Shi Y; Andhey PS; Ising C; Wang K; Snipes LL; Boyer K; Lawson S; Yamada K; Qin W; Manis M; Serrano JR; Benitez BA; Schmidt RE; Artyomov M; Ulrich JD; Holtzman DM
    Neuron; 2021 Aug; 109(15):2413-2426.e7. PubMed ID: 34157306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
    Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
    Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.
    Fryer JD; Demattos RB; McCormick LM; O'Dell MA; Spinner ML; Bales KR; Paul SM; Sullivan PM; Parsadanian M; Bu G; Holtzman DM
    J Biol Chem; 2005 Jul; 280(27):25754-9. PubMed ID: 15888448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
    Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
    Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
    Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurometabolic roles of ApoE and Ldl-R in mouse brain.
    Lee J; Choi J; Wong GW; Wolfgang MJ
    J Bioenerg Biomembr; 2016 Feb; 48(1):13-21. PubMed ID: 26686234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.
    Rebeck GW; Reiter JS; Strickland DK; Hyman BT
    Neuron; 1993 Oct; 11(4):575-80. PubMed ID: 8398148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C; Briand O; Lestavel S; Clavey V; Altenburg M; Maeda N
    Biochim Biophys Acta; 2004 Aug; 1684(1-3):8-17. PubMed ID: 15450205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) alleles contributes to normal variation in lipid level.
    Pedersen JC; Berg K
    Clin Genet; 1989 May; 35(5):331-7. PubMed ID: 2569368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
    Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
    J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
    Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
    Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.
    Zou F; Gopalraj RK; Lok J; Zhu H; Ling IF; Simpson JF; Tucker HM; Kelly JF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Bennett DA; Crook JE; Younkin SG; Estus S
    Hum Mol Genet; 2008 Apr; 17(7):929-35. PubMed ID: 18065781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):14-28. PubMed ID: 10685027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential genetic markers of sporadic Alzheimer's dementia.
    Retz W; Thome J; Durany N; Harsányi A; Retz-Junginger P; Kornhuber J; Riederer P; Rösler M
    Psychiatr Genet; 2001 Sep; 11(3):115-22. PubMed ID: 11702052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease.
    Cheng D; Huang R; Lanham IS; Cathcart HM; Howard M; Corder EH; Poduslo SE
    J Med Genet; 2005 Feb; 42(2):129-31. PubMed ID: 15689450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.